feed,title,long_url,short_url
SeekingAlpha,NewAge shares slip 1% postmarket on lower-than-expected prelim net revenue in Q4,https://seekingalpha.com/news/3786895,
SeekingAlpha,Allogene closes down 9% despite lifting of clinical hold; other gene editing names mixed,https://seekingalpha.com/news/3786894,
